Section Styles full-width

Utepreva is the first endometrial biopsy sampler to detect endometrial cancer before symptoms appear. Utepreva officially launched at ACOG Conference 2026 in DC.

growth stage: LAUNCH

Actions

  • AUDIENCE SEGMENTATION

  • BRAND STRATEGY

  • brand messaging

  • WEBSITE content development

  • launch activation

the ask

Utepreva is an endometrial cancer detection device built on a hard truth: too many women are diagnosed too late.

Founded by a surgeon who saw the gap firsthand, it gives clinicians earlier answers — so patients reach them while more is still possible. Their founding team asked us to develop and launch a brand system that speaks to physicians with precision, warmth, and practicality, while never flinching from what’s at stake for women’s lives.

Section Styles full-width

Strategy

Making early the standard

At the heart of the brand is a reframe: early detection isn't about fear, it's about possibility. Utepreva sells to clinicians, so every word has to earn clinical trust — precise, evidence-backed, regulatory-sound — without losing the human weight of the work. The result is a voice that's honest and unflinching but always uplifting: the tool that helps you catch what others miss.

Project and client teams

Studio: Vitamin Pack
Creative Director: Angela Goleme
Design Director: Patrick Allison
Brand strategist: Menaka Iyer

HEad of brand: Shauna Faulisi
Co-FOUNDER: Dr. Jeanetta Stega.
CO-FOUNDER: Dr. Damian Stega
COMMERCIAL LEAD: Peter Faulisi

“We were amazed by the way Menaka and the Vitamin Pack team threaded the needle between our clinical and business goals — while creating a brand that will resonate with women as we grow.

Shauna Faulisi, Head of Brand